Wilson Sonsini tops Life Sciences Law Firm Index for 2nd straight year
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
presented by
Finding a way through a tight deal space
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Life Sciences Law Firm Index: Thought Leadership Category Update
In January 2016, in collaboration with Lake Whillans and our sister site Above the Law, we published the inaugural Life Sciences Law Firm Index to help identify which law firms are the most active and relevant for life science companies. The goal of the Index is to inform innovators about which firms are the leaders in the […]
M&A: The Last Refuge for Biotechs Seeking Funding
These are tough times in the biotech and pharmaceutical industries: Funding is drying up, investors are fleeing the space, the IPO door is pretty firmly shut, valuations are dropping, activists are lurking and the headlines are anything but kind. But when the going gets tough, the tough consider strategic alternatives. Stuart Falber and Belinda Juran, […]
Wilson Sonsini, WilmerHale and Cooley top new Life Sciences Law Firm Index
The life sciences — particularly in biotechnology and pharmaceuticals — are among the very few industries where companies insist on industry-specialized advisors. The complex life cycle of a life sciences product demands a broad range of legal and business expertise across many practice specialties, combined with deep scientific knowledge. The stakes are increasing particularly when […]